Elanco Animal Health Incorporated (ELAN) Dividend History

Company News

• Animal Health Elanco Chirps A Solid Quarter Tempered By Soft Q2 EPS Guide

  Elanco Animal Health reported a strong Q1 2025 with adjusted EPS beating guidance and consensus. However, the company provided a soft Q2 EPS guidance, leading to a mixed sentiment. The company raised its full-year 2025 revenue guidance but maintained its adjusted EBITDA and EPS ranges.

  Benzinga
• Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal

  Elanco Animal Health has sold certain future royalties and commercial milestones associated with its Xdemvy product to Blackstone for $295 million. The company will use the proceeds to reduce its debt and expects to achieve a net leverage ratio of 3.9x-4.3x EBITDA by the end of 2025.

  Benzinga

  Featured Companies: TARS
• Shareholder Alert: Johnson Fistel, LLP Investigates Elanco Animal Health, Fox Factory Holding, Fidelity National Information, and Bank of America —Long-Term Investors are Encouraged to Contact the Firm

  Johnson Fistel, LLP is investigating potential violations of federal and state laws by officers and directors of Elanco Animal Health, Fox Factory Holding, Fidelity National Information, and Bank of America. The firm is encouraging long-term investors to contact them regarding these investigations.

  GlobeNewswire Inc.

  Featured Companies: BAC FIS FOXF
• Poultry Vaccine & Drug Market Booming as Demand for Disease Prevention Increases

  The poultry pharmaceuticals market is dominated by vaccines due to rising concerns over infectious diseases and regulatory restrictions on antibiotics. The market is projected to reach $6.68 billion by 2029, driven by increasing poultry consumption and the need for effective disease management.

  GlobeNewswire Inc.

  Featured Companies: PAHC
• Growth Trends in the Porcine Vaccines Market, Forecast to 2028: Increasing Government Initiatives for Funding Animal Husbandry

  The porcine vaccine market is forecasted to grow by USD 709.6 million during 2023-2028, driven by increasing prevalence of porcine diseases, research and development, and growing animal healthcare expenditure.

  GlobeNewswire Inc.

  Featured Companies: MRK PAHC ZTS